BIIB icon

Biogen
BIIB

Upgrade to unlock
Buy
Hold
Sell

16 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$201
5% upside
High target

16 analyst ratings

positive
9  neutral
56%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Emily Field
20 Feb ‘26 8 days ago
Wedbush
Wedbush
Laura Chico
10 Feb ‘26 18 days ago
Canaccord Genuity
Canaccord Genuity
Sumant Kulkarni
50% 1-yr BIIB win rate
9 Feb ‘26 19 days ago
BMO Capital
BMO Capital
Evan Seigerman
9 Feb ‘26 19 days ago
TD Cowen
TD Cowen
Phil Nadeau
0% 1-yr BIIB win rate
9 Feb ‘26 19 days ago
Citigroup
Citigroup
Geoff Meacham
9 Feb ‘26 19 days ago
RBC Capital
RBC Capital
Brian Abrahams
86% 1-yr BIIB win rate
9 Feb ‘26 19 days ago
Guggenheim
Guggenheim
Yatin Suneja
0% 1-yr BIIB win rate
9 Feb ‘26 19 days ago
Wells Fargo
Wells Fargo
Mohit Bansal
9 Feb ‘26 19 days ago
Truist Securities
Truist Securities
Srikripa Devarakonda
100% 1-yr BIIB win rate
9 Feb ‘26 19 days ago
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
75% 1-yr BIIB win rate
9 Feb ‘26 19 days ago
Piper Sandler
Piper Sandler
David Amsellem
9 Feb ‘26 19 days ago
Oppenheimer
Oppenheimer
Jay Olson
100% 1-yr BIIB win rate
30 Jan ‘26 29 days ago
UBS
UBS
Michael Yee
7 Jan ‘26 1 month ago
Morgan Stanley
Morgan Stanley
Matthew Harrison
12 Dec ‘25 2 months ago
HSBC
HSBC
Rajesh Kumar
0% 1-yr BIIB win rate
10 Dec ‘25 2 months ago